Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second-line”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01386242
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 108
Not applicableUnknownNCT03692442
What this trial is testing

Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform

Who this might be right for
Lung Cancer Non-small Cell Stage IV
Guangzhou Institute of Respiratory Disease 80
Testing effectiveness (Phase 2)Study completedNCT01553539
What this trial is testing

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

Who this might be right for
Bone CancerChondrosarcomaClear Cell Sarcoma of the Kidney+9 more
Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Study completedNCT00903175
What this trial is testing

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Novartis Pharmaceuticals 471
Large-scale testing (Phase 3)Looking for participantsNCT06195709
What this trial is testing

ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

Who this might be right for
Breast Carcinoma
Institut Curie 300
Testing effectiveness (Phase 2)Ended earlyNCT02461134
What this trial is testing

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD

Who this might be right for
Chronic Graft Versus Host Disease
Actelion 1
Testing effectiveness (Phase 2)Study completedNCT05278728
What this trial is testing

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 31
Not applicableStudy completedNCT03091465
What this trial is testing

Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib

Who this might be right for
Metastatic Renal Cell Carcinoma
Spanish Oncology Genito-Urinary Group 530
Testing effectiveness (Phase 2)Looking for participantsNCT06213311
What this trial is testing

Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma

Who this might be right for
B Cell Lymphoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00494481
What this trial is testing

E3 Breast Cancer Taxotere Combination

Who this might be right for
Advanced Breast Cancer
Genzyme, a Sanofi Company 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07229872
What this trial is testing

A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Immunodominant pMMR/MSS Metastatic Colorectal Cancer That Has Failed Second-line or Above Treatment

Who this might be right for
Colorectal Cancer
Harbin Medical University 18
Testing effectiveness (Phase 2)Looking for participantsNCT07704177
What this trial is testing

Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07420439
What this trial is testing

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Who this might be right for
Non Small Cell Lung Cancer MetastaticInterstitial Lung Disease (ILD)
Intergroupe Francophone de Cancerologie Thoracique 108
Not applicableStudy completedNCT02072967
What this trial is testing

Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Astellas Pharma Europe B.V. 97
Testing effectiveness (Phase 2)Looking for participantsNCT06929936
What this trial is testing

Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerMyelosuppression
The First Affiliated Hospital of Xiamen University 33
Early research (Phase 1)Not Yet RecruitingNCT07031011
What this trial is testing

PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer

Who this might be right for
Advanced Gastric or Colorectal Cancer
jiuwei cui 22
Early research (Phase 1)Study completedNCT00478634
What this trial is testing

Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)UnknownNCT03634332
What this trial is testing

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreatic Neoplasms
Pancreatic Cancer Research Team 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421
What this trial is testing

Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)Study completedNCT00191971
What this trial is testing

2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen

Who this might be right for
Urologic NeoplasmsCarcinoma, Transitional Cell
Eli Lilly and Company 40
Next Page